Company profile: Microchips Biotech
1.1 - Company Overview
Company description
- Provider of a proprietary microchip-based implant for long-term, precise drug delivery. The subcutaneous device stores and releases exact doses over months and years and is placed under the skin by a trained physician in a simple office procedure using local anesthesia.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Microchips Biotech
Heppe Medical Chitosan
HQ: Germany
Website
- Description: Provider of pure biopolymers and nanoparticles based on chitin and chitosan for cosmetic and pharmaceutical applications, offering GMP chitosan and chitosan derivatives; microfluidics for chitosan-TPP nanoparticles for drug delivery; 3D bioprinted chitosan networks for dental use; cisplatin-chitosan microparticles for breast implants; and biodegradable antibacterial chitosan-based masks.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Heppe Medical Chitosan company profile →
Guava Technologies
HQ: United States
Website
- Description: Provider of biotechnology and medical devices, including unique flow cytometry and benchtop cell analysis systems. Offers HIV/AIDS monitoring, viacount cell counting and viability assays, antibody quantification, apoptosis assay suite, cell cycle, cytotoxicity, and cell proliferation assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guava Technologies company profile →
Dewpoint Therapeutics
HQ: United States
Website
- Description: Provider of condensate-modifying drugs and an AI-powered drug discovery platform focused on biomolecular condensates. Offers therapies targeting TDP-43 for ALS and neurodegenerative diseases and beta catenin for cancers such as colorectal cancer. Engages in partnerships with pharmaceutical companies to develop drugs for cardiovascular diseases, insulin resistance, and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dewpoint Therapeutics company profile →
WITec
HQ: Germany
Website
- Description: Provider of 3D Raman imaging and correlative microscopy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WITec company profile →
Evitria
HQ: Switzerland
Website
- Description: Provider of global antibody expression services specialized in CHO-based transient production of recombinant antibodies, including chimeric, bispecific, Fc-optimized, fusion, afucosylated (GlymaxX) and Fc-silenced (STR) variants. Offers bispecific formats (Duobody, IgG-scFvs, Knobs-into-Holes) and transient expression of secreted proteins (scFvs, extracellular domains, cytokines, viral proteins).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evitria company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Microchips Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Microchips Biotech
2.2 - Growth funds investing in similar companies to Microchips Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Microchips Biotech
4.2 - Public trading comparable groups for Microchips Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →